Lamitias 25mg Tablet

Lamitias 25mg Tablet is an anti-epileptic medication that is used to treat two conditions, epilepsy and bipolar disorder. It works by blocking the signals in the brain that trigger epileptic seizures (fits) and in another way to prevent extreme mood swings.

Lamitias 25mg Tablet can be used alone or in combination with other medicines. It may be taken with or without food. Your doctor will decide the correct dose for you. This may increase gradually until your condition is stable. This medicine may take several weeks to work but it is important to take it regularly to get the maximum benefit. Do not stop taking it, even if you feel fine unless your doctor advises you to. You may have more seizures, or your bipolar disorder may get worse.

The most common side effects of this medicine include skin rashes, headache, nausea, and vomiting, difficulty sleeping, and dizziness. Most side effects wear off, but if they bother you or do not go away, tell your doctor. Inform your doctor immediately if you notice a rash or peeling of the skin. There may be ways of preventing or reducing these effects. Long-term treatment can cause weakness in your bones (osteoporosis), increasing your risk of breaking a bone.

Before taking this medicine, tell your doctor if you have kidney or liver problems, depression, or suicidal thoughts. Also let your healthcare professional know about all other medications you are using as some may affect, or be affected by, this medicine, including contraceptive pills. Consult your doctor if you are pregnant or breastfeeding as the dose may need to be adjusted. You should avoid driving or anything that requires concentration if this medicine makes you drowsy or dizzy. You may need frequent blood tests to check how you are responding to this medicine.

• Epilepsy/Seizures
• Bipolar disorder

Epilepsy/Seizures
Lamitias 25mg Tablet is used alone or with other medicines to prevent and control seizures (fits). It works by decreasing the nerve impulses that cause seizures. It can help reduce symptoms such as confusion, uncontrollable jerking movements, loss of awareness, and fear or anxiety. By controlling the frequency of seizures, it will help you go about your daily activities with more confidence. It may also allow you to do some activities that you would otherwise be forbidden or scared to do (such as swimming and driving). This medicine may take several weeks or months to work effectively as the dose is adjusted. Carefully follow all instructions and never take more tablets than your doctor tells you to. It needs to be taken regularly as prescribed to be most effective.

Bipolar disorder
Lamitias 25mg Tablet works to restore the normal balance of nerve activity in your brain. It is sometimes called a mood stabilizer and can help prevent extreme changes in mood and help you feel less agitated. You may experience fewer episodes of depression and low mood. It can take several weeks for this medicine to work and you may still feel low during this time. It is likely that you will take this medicine for at least six months but possibly much longer. It needs to be taken regularly to work effectively. Do not stop taking it unless your doctor advises you to. You should continue to eat well and keep fit to reduce symptoms of bipolar disorder.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Flylep

• Skin rash
• Headache
• Nausea
• Vomiting
• Dryness in mouth
• Insomnia (difficulty in sleeping)
• Sleepiness
• Dizziness
• Back pain
• Abdominal pain
• Blurred vision
• Double vision
• Impaired coordination
• Nasal congestion (stuffy nose)
• Infection

Take this medicine in the dose and duration as advised by your doctor. Dissolve it in a glass of water before taking it. Lamitias 25mg Tablet may be taken with or without food, but it is better to take it at a fixed time.

Lamitias 25mg Tablet is an antiepileptic medication. It controls seizures or fits by decreasing the abnormal and excessive activity of the nerve cells in the brain.

• Take your medication regularly as directed by your doctor as missing doses can trigger seizures.

• Do not change the brand of your medicine and make sure that you have sufficient amount of medicine present with you.

• Some healthy tips to prevent seizures:

  • Practice yoga every day.
  • Get enough sleep at nighttime.
  • Limit the use of screen time such as mobile/laptop.
  • Take your medication on time.

• It may cause headaches. Drink plenty of water and take a suitable pain killer. Inform your doctor if it does not go away.

• It may cause skin rash. Inform your doctor immediately if you notice a rash, itching and peeling of skin.

• Talk to your doctor if you notice sudden mood changes or develop suicidal thoughts.

• Do not stop taking the medication suddenly without talking to your doctor as it may increase the frequency of seizure.

Stahl SM, editor. Lamotrigine. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 325-32.

McNamara JO. Pharmacotherapy of the Epilepsies. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 599-600.

Porters RJ, Meldrum BS. Antiseizure Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 409.

Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 771-74.

Lamotrigine. Uxbridge, Middlesex: GlaxoSmithKline UK; 1991 [revised 24 Oct. 2018]. [Accessed 23 Jan. 2019] (online) Available from:

Lamotrigine. Greenville, NC: GlaxoSmithKline; 2009. [Accessed 25 Mar. 2019] (online) Available from:

Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198. [Accessed 20 Mar. 2019] (online) Available from:

Central Drugs Standard Control Organisation (CDSCO). [Accessed 25 Mar. 2019] (online) Available from: